Now showing items 1-2 of 2
Big Pharma's internationalization of R&D to China
(Taylor & Francis, 2015-04-18)
China's increasing integration into the global pharmaceutical value chain is occurring at a time when big pharma's traditional R&D model has entered a period of crisis, and when China faces significant challenges in providing ...
China's increasing participation in ICT's global value chain: A firm level analysis
This paper synthesises evidence from international trade data of China-based ICT companies in order to map their involvement in the ICT global value chain (GVC). The ICT GVC is divided into three types of companies: Own ...